In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed
Popular Posts
-
The idea behind the proposed changes to IBC regulations is to bring more transparency and procedural fairness to corporate insolvency resol...
-
A regulatory asset is an intangible asset created by electricity discoms to account for the gap between the price at which they purchase po...
